Marksans Pharma Limited Stock price

Equities

MARKSANS

INE750C01026

Pharmaceuticals

Market Closed - NSE India S.E. 11:43:36 23/02/2024 GMT 5-day change 1st Jan Change
158 INR -0.44% Intraday chart for Marksans Pharma Limited -5.33% -1.96%

Financials

Sales 2024 * 21.58B 261M 20.56B Sales 2025 * 26.33B 318M 25.09B Capitalization 71.58B 864M 68.2B
Net income 2024 * 3.34B 40.26M 3.18B Net income 2025 * 4.07B 49.08M 3.87B EV / Sales 2024 * 3.32 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 2.72 x
P/E ratio 2024 *
21.5 x
P/E ratio 2025 *
17.6 x
Employees 852
Yield 2024 *
-
Yield 2025 *
-
Free-Float 56.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.44%
1 week-5.33%
Current month+1.67%
1 month+5.19%
3 months+9.16%
6 months+39.22%
Current year-1.96%
More quotes
1 week
152.40
Extreme 152.4
167.90
1 month
138.50
Extreme 138.5
170.85
Current year
138.50
Extreme 138.5
179.30
1 year
64.30
Extreme 64.3
179.30
3 years
38.60
Extreme 38.6
179.30
5 years
9.85
Extreme 9.85
179.30
10 years
9.85
Extreme 9.85
179.30
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 15/04/92
Director of Finance/CFO 54 05/09/02
Compliance Officer - -
Members of the board TitleAgeSince
Director/Board Member 49 10/08/21
Chief Executive Officer 52 15/04/92
Director/Board Member 52 24/09/14
More insiders
Date Price Change Volume
23/02/24 158 -0.44% 930,741
22/02/24 158.6 +1.60% 755,119
21/02/24 156.2 -2.16% 1,090,589
20/02/24 159.6 -1.18% 1,363,616
19/02/24 161.5 -3.21% 1,644,544

Delayed Quote NSE India S.E., February 23, 2024 at 11:43 am

More quotes
Marksans Pharma Limited is an India-based pharmaceutical company. The Company is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations. The Company produces goods across various therapeutic areas, such as pain management, cough and cold, cardiovascular and central nervous system, anti-diabetic, gastrointestinal, hormonal treatment, and anti-allergic, among others. The Company operates four manufacturing facilities across India, the United Kingdom and the United States. The Company manufactures oral solid tablets, soft gelatin capsules and hard capsules in Goa. It also manufactures non-sterile liquids, ointments and powder products and caters to the United Kingdom, West Africa and the Middle East, which is located in the United Kingdom. The Company has spread its facility to over 7000 square meters and manufactures tablets and capsules in the United States.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
158
Average target price
-
Spread / Average Target
-100.00%
Consensus

Annual profits - Rate of surprise

1st Jan change Capi.
-1.96% 864 M $
+32.01% 693 B $
+21.62% 550 B $
+3.25% 390 B $
+18.74% 328 B $
+14.92% 315 B $
+7.97% 213 B $
-4.95% 212 B $
-3.58% 201 B $
-3.58% 157 B $
Other Pharmaceuticals
  1. Stock
  2. Equities
  3. Stock Marksans Pharma Limited - NSE India S.E.
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer